News

OPKO Health, Inc. (NASDAQ:OPK) is one of the Best American Penny Stocks to Buy According to Analysts. On July 8, OPKO Health, ...
Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation Itolizumab in combination with systemic corticosteroids was associated ...
Clinical data supporting mechanism of action reinforce potential as a novel cancer treatmentBRISBANE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a ...
Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, will be sharing a poster ...
Carlsbad, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for ...
NATICK, Mass. (Aug. 11, 2016) -- The U.S. Army Natick Soldier Research, Development and Engineering Center held its 10th Annual Future Workforce Poster Presentation, showcasing science and ...
This month, Mr. Nowak will host an in-depth discussion of "Alt Fi" investment opportunities, such as merchant cash advance, Regulation A+, factoring, syndication and participations. Mr.
The poster presentation is available on the Presentations page of Equillium’s website under the “Itolizumab MOA” tab. About Itolizumab ...